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Social Determinants of Health and Care Outcomes Among 
People With HIV in the United States
Timothy W. Menza,1,2,  Lindsay K. Hixson,1 Lauren Lipira,1,3 and Linda Drach1
1Public Health Division, Oregon Health Authority, Portland, Oregon, USA, 2Division of Infectious Diseases, Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA, 
and 3School of Social Work, Regional Research Institute, Portland State University, Portland, Oregon, USA
Background. Fewer than 70% of people with HIV (PWH) in the United States have achieved durable viral suppression. To end the 
HIV epidemic in the United States, clinicians, researchers, and public health practitioners must devise ways to remove barriers to effective 
HIV treatment. To identify PWH who experience challenges to accessing health care, we created a simple assessment of social determin-
ants of health (SDOH) among PWH and examined the impact of cumulative social and economic disadvantage on key HIV care outcomes.
Methods. We used data from the 2015–2019 Medical Monitoring Project, a yearly cross-sectional survey of PWH in the United States 
(n = 15 964). We created a 10-item index of SDOH and assessed differences in HIV care outcomes of missed medical appointments, med-
ication adherence, and durable viral suppression by SDOH using this index using prevalence ratios with predicted marginal means.
Results. Eighty-three percent of PWH reported at least 1 SDOH indicator. Compared with PWH who experienced none of the 
SDOH indicators, people who experienced 1, 2, 3, and 4 or more SDOH indicators were 1.6, 2.1, 2.6, and 3.6 as likely to miss a med-
ical appointment in the prior year; 11%, 17%, 20%, and 31% less likely to report excellent adherence in the prior 30 days; and 2%, 
4%, 10%, and 20% less likely to achieve durable viral suppression in the prior year, respectively.
Conclusions. Among PWH, cumulative exposure to social and economic disadvantage impacts care outcomes in a dose-
dependent fashion. A simple index may identify PWH experiencing barriers to HIV care, adherence, and durable viral suppression 
in need of critical supportive services.
Keywords.  adherence; HIV; missed appointments; social determinants of health;  viral suppression.
Major biomedical advances in HIV care have improved the 
lives of people with HIV (PWH); the life expectancy of PWH 
receiving effective HIV antiretroviral therapy (ART) is now 
nearly equivalent to people without HIV [1]. However, even 
within high-resource contexts like the United States, disparities 
in HIV care outcomes by race and ethnicity, age, and gender 
persist [2–4]. For example, Black/African American PWH are 
less likely to receive adequate medical care, including ART, and 
achieve viral suppression compared with PWH from other ra-
cial/ethnic groups [4]. Compared with elders with HIV, youth 
with HIV are less likely to be diagnosed with HIV, be linked 
to and retained in care, and experience viral suppression [5]. 
Transgender PWH are less likely to report excellent adherence 
to ART and achieve viral suppression compared with cisgender 
PWH [6, 7]. Comprehensive services, like those provided 
through the Ryan White HIV/AIDS Program (Ryan White), 
have been effective at reducing some disparities, but not all [8]. 
Understanding, measuring, and addressing the fundamental 
causes of HIV-related disparities are essential [9–11].
Social determinants of health (SDOH) are fundamental 
causes of health disparities and, according to the US Centers 
for Disease Control and Prevention (CDC), refer to the “con-
ditions in the environments in which people are born, live, 
learn, work, play, worship and age that affect a wide range of 
health, functioning, and quality of life outcomes and risks” [12]. 
SDOH reflect the social, political, and economic contexts and 
social hierarchies whereby populations are stratified according 
to attributes such as income, gender, race, ethnicity, education, 
occupation, and other factors [13]. These hierarchies, in turn, 
determine an individual’s exposure to material conditions, bi-
ological and behavioral factors, psychosocial factors, and inter-
actions with the health care system (ie, SDOH) that may either 
promote or compromise wellness. In Healthy People 2020, the 
CDC recognized 5 key areas of SDOH: economic stability, ed-
ucation, social and community context, health and health care, 
and neighborhood and built environment [12].
The relationship between SDOH and HIV care outcomes 
(eg, adherence to ART, attendance to medical appointments, 
and viral suppression) is largely recognized [14], but most re-
search and reporting has focused on associations between a 
single factor (eg, poverty, food insecurity, incarceration, or 
homelessness) and clinical outcomes [9, 15, 16]. Similarly, the 
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CDC reported on county-level social determinants among 
PWH, but examined only 4 items—poverty, education level, 
median household income, and health insurance coverage [17]. 
However, SDOH are complex, intersecting, and reinforcing 
[11].
The best method to assess the cumulative effects of SDOH on 
health outcomes has not yet been determined. However, the ad-
ditive nature of SDOH is clearly reflected in medical case man-
agement for PWH [18]. Nationwide, Ryan White case managers 
base the level of prescribed client support and services on a cu-
mulative assessment of biopsychosocial factors, or acuity scale. 
Still, a thorough acuity scale can be time-intensive, and case 
management may not be available for all PWH or incorporated 
into all HIV-related health encounters. Furthermore, to date, no 
SDOH scales have been validated for use in large-scale surveil-
lance or research designed to identify PWH at risk for poorer 
HIV care outcomes. A short, easily constructed index of SDOH 
could provide clear clinical and public health benefits.
We explored how the accumulation of SDOH across sev-
eral relevant domains influences the health outcomes of PWH 
and propose an index that can be used to measure the effect 
of SDOH on key HIV care outcomes of missed appointments, 
treatment adherence, and viral suppression. In addition, we ex-
plored how this index performs in the presence of demographic 
variables of age, race/ethnicity, and a combined measure of 
gender and gender of sex partners that are associated with the 
HIV care outcomes of interest. Finally, we assessed the residual 
associations between demographic characteristics and care out-
comes after accounting for SDOH.
METHODS
Data Set
We used data from the CDC Medical Monitoring Project 
(MMP), which produces nationally and locally representa-
tive data to assess the clinical and behavioral characteristics of 
adults with diagnosed HIV infection in the United States and 
Puerto Rico [5]. MMP uses a complex survey sample selected 
in 2 consecutive stages. First, 16 states and 1 territory were 
selected from all US states, the District of Columbia, and Puerto 
Rico. Next, simple random samples of adults with diagnosed 
with HIV infection aged ≥18 years were taken within each sam-
pled jurisdiction from the National HIV Surveillance System 
(NHSS), a census of PWH in the US MMP whose data are col-
lected annually from June of each cycle year through May of the 
following year. For this analysis, we used 4 cycle years of pooled 
national data, collected during June 2015 through May 2019, 
for these analyses (n = 15  964). Demographic, clinical, and 
behavioral data were collected through face-to-face or phone 
interviews. Relevant clinical data (eg, prescription of antiretro-
viral therapy [ART] medications and laboratory results) were 
abstracted from medical records. The annual response rate for 
jurisdictions was 100%, and for sampled persons it ranged from 
40% to 46% for the data cycle years included in the study [5].
Patient Consent
In accordance with guidelines for defining public health re-
search, the Centers for Disease Control and Prevention deter-
mined that the Medical Monitoring Project was public health 
surveillance used for disease control, program, or policy pur-
poses. Local institutional review board approval was obtained 
within participating jurisdictions when required. Informed 
consent was obtained from all interviewed participants.
Measures
We constructed the Oregon Social Determinants of HIV Health 
Index (OSHI) using the 5 domains of Healthy People 2020—edu-
cation, economic stability, health, neighborhood and built environ-
ment, and social and community context—as a framework [12]. 
We chose 2 items from the MMP core survey that best mapped 
to each of the 5 domains (Table 1). All data used to construct the 
10-item OSHI were collected through participant interviews. We 
then summed the number of items reported by the participant 
to create the OSHI, which has a range of 0 to 10, where higher 
scores indicate that the respondent was experiencing a higher 
level of social, environmental, or economic disadvantage. From 
Table 1. Oregon Social Determinants of HIV Health Index Items and 
Definitions Derived From the CDC Medical Monitoring Project
OSHI Item Definition
Education  
 Education level Less than high school (vs all other)
 Health literacy Somewhat/a little bit/not a bit confident in filling out 
medical forms by yourself (vs extremely or quite 
a bit confident)
Economic stability  
 Poverty Income at or below the federal poverty guideline 
 Food insecurity Past-year experiences of being hungry but didn’t eat 
because there wasn’t enough money for food 
Health  
 Gap in health 
coverage
Past-year gap in health insurance





 Homelessness Past-year experience of homelessness (defined as 
lived in a shelter/car/single room occupancy hotel)
 Need for trans-
portation help




 Criminal justice 
involvement
Past-year experience of being arrested and put in 
jail/detention/prison for longer than 24 h
 History of sexual/
physical IPV 
Any history of sexual or physical intimate partner 
violence
Abbreviations: CDC, Centers for Disease Control and Prevention; ER, emergency room; 
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the continuous OSHI, we created a 5-level ordinal OSHI variable 
based on the distribution of the 10 individual indicators: 0 SDOH 
indicators, 1 SDOH indicator, 2 SDOH indicators, 3 SDOH indi-
cators, and 4 or more SDOH indicators.
We examined 3 dichotomous HIV care continuum measures: 
missed appointments, adherence to ART, and durable viral sup-
pression. Missed appointments and ART adherence data were 
collected through patient interviews; viral suppression data 
were collected through medical record abstraction. Missed ap-
pointments were defined as whether participants had missed 
any HIV-related medical appointments in the past year (yes/
no). An analysis of a US clinical cohort of PWH engaged in care 
showed that patients who missed appointments experienced 
greater mortality than those who did not [19]. Excellent ART 
adherence was defined as not missing any doses of HIV medica-
tions in the past 30 days (yes/no). Durable viral suppression was 
defined as having all (not just the most recent) viral loads unde-
tectable or <200 copies/mL in the past 12 months. Durable viral 
suppression prevents HIV-related complications, extends life 
expectancy, and prevents secondary HIV transmission [1, 20].
We examined 4 key sociodemographic covariates associated 
with the care outcomes of interest and SDOH: age (measured in 
years as a categorical variable: 18–29, 30–39, 40–49, and ≥50); 
race/ethnicity (White, non-Hispanic; Black, non-Hispanic; 
Hispanic/Latinx; and an “other race” category to capture the rel-
atively low numbers of American Indian/Alaska Native, Asian, 
Pacific Islander, and multiracial participants); and a combined 
variable indicating gender and sex partner gender (any men 
who have sex with men [MSM], men who have sex with women 
only [MSW], any women who have sex with men [WSM], and 
an “other” category that includes the relatively low numbers of 
transgender individuals and women who have sex with women).
Statistical Analysis
We calculated weighted percentages and corresponding 95% 
confidence intervals of the sociodemographic variables and the 
individual OSHI items and the 5-level categorical OSHI overall 
and by HIV care outcome. We also calculated the mean and 
median OSHI and corresponding 95% CIs overall and by care 
outcome.
We estimated unadjusted prevalence ratios (PRs) with pre-
dicted marginal means using logistic regression to examine the 
associations between individual OSHI items and missed ap-
pointments, excellent ART adherence, and durable viral sup-
pression. We then estimated unadjusted prevalence ratios to 
assess the associations between the 5-level categorical OSHI 
and missed appointments, excellent ART adherence, and du-
rable viral suppression, respectively (Models 1–3). Models 4–6 
examined the associations between the categorical OSHI vari-
able and the 3 outcomes of interest, with each model adjusted 
for age, race/ethnicity, and a combined measure of gender and 
sex partner gender.
Data were weighted based on known probabilities of selec-
tion at state or territory and person levels. In addition, data were 
weighted to adjust for person nonresponse and poststratified 
to known population totals by age, race/ethnicity, and gender 
from NHSS [5]. Statistical tests with P < .05 were considered 
significant. All analyses were conducted using survey proced-
ures in SAS 9.4 and SAS-callable SUDAAN 11.0.1.
RESULTS
Characteristics and Distribution of Social Determinants of Health Among 
PWH in the United States
Among PWH in the United States, half were 50  years of age 
or older, and half were MSM. Forty-one percent were non-
Hispanic Black, nearly one-third were non-Hispanic White, 
and 22% were Hispanic/Latinx (Table 2). Seventeen percent 
(17%) experienced none of the SDOH indicators, 23% 1 indi-
cator, 20% 2 indicators, 16% 3 indicators, and 25% 4 or more 
indicators. The most frequently reported SDOH indicator was 
poverty (43%), followed by a past-year visit to the emergency 
room (39%). One-third had experienced intimate partnet vi-
olence (IPV; 33%) or needed transportation assistance (32%), 
and almost one-quarter (24%) reported needing help com-
pleting medical forms. About 1 in 5 PWH had less than a high 
school diploma (18%) or were experiencing food insecurity 
(21%); 1 in 10 experienced homelessness (9%) or had a gap in 
health insurance (12%). Five percent experienced criminal jus-
tice involvement. The mean OSHI was 2.30 (95% CI, 2.25–2.35) 
with a median of 1.52 (95% CI, 1.45–1.59).
Clinical Outcomes by the Oregon Social Determinants of HIV Health Index
Twenty-four percent missed HIV medical appointments in the 
prior year, 60% had excellent adherence to their HIV medica-
tions in the prior 30 days, and 63% had achieved durable viral 
suppression in the prior 12 months (Table 3). All 10 SDOH indi-
cators were associated with a missed HIV medical appointment, 
all SDOH indicators except for education level were associated 
with excellent ART adherence, and all SDOH indicators except 
for health literacy and history of IPV were associated with viral 
suppression. The mean and median OSHI were 3.13 (95% CI, 
3.05–3.21) and 2.49 (95% CI, 2.39–2.59), respectively, for those 
who missed an appointment in the prior year, compared with 
2.04 (95% CI, 1.98–2.09) and 1.25 (95% CI, 1.17–1.32), respec-
tively, for those who did not miss an appointment. The mean 
and median OSHI were 2.01 (95% CI, 1.96–2.06) and 1.22 (95% 
CI, 1.14–1.29), respectively, for those who reported excellent 
adherence and 2.57 (95% CI, 2.50–2.64) and 1.79 (95% CI, 
1.70–1.89), respectively, for those who did not report excellent 
adherence. Finally, the mean and median OSHI were 2.12 (95% 
CI, 2.06–2.17) and 1.34 (95% CI, 1.27–1.41), respectively, for 
those who were durably virally suppressed compared with 2.64 
(95% CI, 2.56–2.73) and 1.89 (95% CI, 1.77–2.02), respectively, 
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We observed a dose–response relationship between SDOH 
indicators and clinical outcomes in unadjusted analysis (Table 
4, Models 1–3). Compared with those with an OSHI of 0, those 
with a score of 1, 2, 3, and 4 or greater were 1.6, 2.2, 2.9, and 4.0 
times as likely to miss an appointment, respectively. Compared 
with those with an OSHI of 0, those with a score of 1, 2, 3, and 
4 or greater were 11%, 17%, 20%, and 31% less likely to report 
excellent ART adherence and were 3%, 6%, 12%, and 23% less 
likely to achieve durable viral suppression, respectively.
In the models adjusted for sociodemographic characteristics 
(Table 5, Models 4–6), the categorical OSHI remained signif-
icantly associated with each of the HIV clinical outcomes in a 
dose-dependent fashion. Compared with those with an OSHI of 
0, PWH with an index of 1, 2, 3, and 4 or greater were 1.6, 2.1, 
2.6, and 3.6 times as likely to miss a medical appointment, re-
spectively. Compared with those with an OSHI of 0, those with a 
score of 1, 2, 3, and 4 or greater were 11%, 17%, 20%, and 31% less 
likely to report excellent adherence and were 2%, 4%, 10%, and 
20% less likely to achieve durable viral suppression, respectively.
In adjusted models, PWH younger than 50 years of age were 
more likely to miss an appointment and less likely to report 
excellent adherence and to achieve durable viral suppression 
compared with those aged 50  years or older. The experiences 
of PWH who identify as Black and Hispanic/Latinx were as-
sociated with missing an appointment in the prior year. In ad-
dition, the experiences of Black PWH were associated with an 
11% lower prevalence of excellent adherence and durable viral 
suppression. MSM, transgender people, and WSW (the “other” 
category of the combined gender and sex partner variable) were 
12% less likely to report excellent adherence than MSW.
In a post hoc analysis, we modified the OSHI to create an 
8-item score by omitting health literacy and history of IPV 
from the index; these 2 items were not statistically signifi-
cantly associated with durable viral suppression in bivariable 
models. Seventy-one percent of PWH experienced at least 1 of 
the SDOH indicators of the 8-item score. In a model adjusted 
for age, race/ethnicity, and gender and sex partner, prevalence 
ratios comparing durable viral suppression among those with a 
score of 0 with those with a score of 1, 2, 3, and 4 or greater were 
0.95 (95% CI, 0.91–0.99; P = .008), 0.89 (95% CI, 0.85–0.94; 
Table 2. Sociodemographic Characteristics and Oregon Social 
Determinants of HIV Health Index Items Among People With HIV in the 
United States, Medical Monitoring Project, 2015–2019
 Total
 No. Col % (95% CI)
Total 15 964 100
Sociodemographics   
Age group, y   
 18–29 1327 8.9 (8.2–9.6)
 30–39 2553 16.6 (15.9–17.3)
 40–49 3781 24.2 (23.3–25.1)
 ≥50 8303 50.3 (49.1–51.6)
Race/ethnicity   
 Black, non-Hispanic 6734 41.1 (36.4–45.9)
 White, non-Hispanic 4662 29.5 (26.4–32.6)
 Hispanic or Latinx 3477 22.3 (18.5–26.2)
 Other 1091 7.0 (6.2–7.9)
Gender and sex partner type   
 Any MSM 7805 49.8 (47.9–51.7)
 MSW only 3558 23.1 (22.0–24.2)
 Any WSM 3981 23.0 (21.8–24.3)
 Other 616 4.1 (3.7–4.4)
OSHI items   
Education   
Education level   
 Less than high school 2851 17.6 (16.5–18.7)
 High school or more 13 050 82.4 (81.3–83.5)
Health literacy   
 Low confidence in completing health forms 3779 24.0 (23.1–24.9)
 High confidence in completing health forms 12 083 76.0 (75.1–76.9)
Economic stability   
Poverty   
 Yes 6553 43.2 (41.2–45.3)
 No 8253 56.8 (54.7–58.8)
Food insecurity   
 Yes 3304 20.8 (20.0–21.7)
 No 12 600 79.2 (78.3–80.0)
Health   
Gap in insurance   
 Yes 1665 11.5 (10.4–12.6)
 No 14 064 88.5 (87.4–89.6)
ER visit   
 Yes 6189 38.7 (37.3–40.1)
 No 9661 61.3 (59.9–62.7)
Neighborhood & built environment   
Homelessness   
 Yes 1460 8.9 (8.3–9.4)
 No 14 452 91.1 (90.6–91.7)
Need for transportation help   
 Yes 5283 31.7 (30.7–32.7)
 No 10 553 68.3 (67.3–69.3)
Social & community context   
Criminal justice involvement   
 Yes 780 5.1 (4.6–5.6)
 No 15 122 94.9 (94.4–95.4)
History of sexual/physical IPV   
 Yes 5231 33.1 (31.6–34.5)
 No 10 491 66.9 (65.5–68.4)
OSHI score categorized   
 Total
 No. Col % (95% CI)
 0 indicators 2354 16.6 (15.7–17.6)
 1 indicator 3212 22.7 (21.6–23.8)
 2 indicators 2938 20.4 (19.5–21.3)
 3 indicators 2273 15.6 (14.8–16.4)
 ≥4 indicators 3659 24.6 (23.6–25.7)
Abbreviations: ART, antiretroviral therapy; ER, emergency room; IPV, intimate partner vio-
lence; MSM, men who have sex with men; MSW, men who have sex with women; WSM, 
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P < .001), 0.84 (95% CI, 0.79–0.88; P < .001), and 0.73 (95% CI, 
0.69–0.77; P < .001), respectively.
DISCUSSION
Among adults with diagnosed with HIV in the United States, 
social and economic disadvantage was highly prevalent. Our 
analysis demonstrated that SDOH are both individually and cu-
mulatively associated with key HIV care outcomes. Controlling 
for age, race/ethnicity, and a combined measure of participant 
gender and gender of sex partners, social and economic disad-
vantage was associated with a greater likelihood of missing an 
appointment with a provider and a lower likelihood of excel-
lent adherence and durable viral suppression. We specifically 
observed a dose–response relationship between the cumulative 
number of SDOH experienced and risk of poorer care out-
comes. In addition, even when accounting for OSHI score, we 
found residual associations between demographic characteris-
tics and HIV care outcomes.
Social and economic disadvantage was commonly re-
ported; 83% of PWH reported at least 1 SDOH. This finding 
is consistent with a recent CDC report that illustrated fre-
quent exposure to county-level measures of poverty, low ed-
ucational attainment, low income, and low health insurance 
coverage among PWH and, like other studies [9, 15, 16], 
demonstrated associations between these individual SDOH 
and HIV care outcomes [17]. In our analysis, we found that 
reporting even 1 SDOH was associated with missed appoint-
ments and poorer ART adherence. As with tobacco use or 
lead exposure, there appears to be no “safe” level of exposure 
to social or economic disadvantage with respect to HIV care 
outcomes [21, 22].
The dose–response association between OSHI score and 
HIV care outcomes corresponds both with our conceptual un-
derstanding of SDOH and research from other fields; SDOH 
are overlapping and interconnected, contributing to cumu-
lative stress, increased allostatic load, and heightened risk of 
chronic disease and further disadvantage over the life course 
[23]. However, to our knowledge, this is the first analysis to 
quantitatively demonstrate the relationship between cumulative 
SDOH and HIV care outcomes.
Still, despite strong associations between the OSHI and HIV 
care continuum measures, disparities by age, race/ethnicity, and 
combined gender and gender of sex partners persisted. Even 
after controlling for OSHI score and other demographics, com-
pared with White PWH, PWH of color, and especially Black 
PWH, had poorer care outcomes. Racial and ethnic disparities 
are frequently attributed to differences in SDOH [24]; however, 
our results indicate that the OSHI does not adequately account 
for differences by race and ethnicity. Racism and other forms of 
discrimination have been conceptually and empirically linked 
to adverse health outcomes in general and in HIV care [25]. 
The CDC recognizes discrimination as a key issue in the so-
cial and community context domain of SDOH [12]. As such, 
the persistent differences across race and ethnicity may be at 
least partially attributable to anticipated racism, direct experi-
ences of racism, and/or medical mistrust resulting from histor-
ical racism [15, 26]. Unfortunately, MMP only began collecting 
recent (ie, in the prior 12 months vs since testing HIV-positive) 
experiences of racism or discrimination related to HIV status, 
age, sexual orientation, or gender identity in 2018. Further re-
finement of the OSHI or use the OSHI in conjunction with ex-
isting measures of racism or other forms of discrimination, may 
more effectively capture SDOH relevant to racial and ethnic dis-
parities in outcomes among PWH.
Similarly, after accounting for SDOH and other demo-
graphics, younger age remained associated with higher risk of 
poor HIV care outcomes. Existing research suggests that low 
self-efficacy and lack of perceived utility of treatment may con-
tribute to poor adherence specifically among young PWH [2]. 
Alternatively, it is possible that older adults do not necessarily 
have better HIV outcomes than young adults. Rather, the as-
sociation could be a product of survival bias; older adults with 
HIV have aged successfully because they have good appoint-
ment attendance, ART adherence, and viral suppression [27]. 
Regardless, our results reiterate the unique impact age has on 
HIV outcomes, potentially independent of SDOH.
Table 4. Unadjusted Prevalence Ratios Comparing Care Outcomes by the Oregon Social Determinants of HIV Health Index Among People With HIV in the 
United States, Medical Monitoring Project, 2015–2019
Model 1  
Missed Appointment
Model 2  
Excellent Adherence
Model 3  
Durable Viral Suppression
 % (95% CI) PR (95% CI) P Value % (95% CI) PR (95% CI) P Value % (95% CI) PR (95% CI) P Value
OSHI score          
0 indicators 9.8 (8.2–11.3) Ref  71.1 (68.9–73.4) Ref  71.8 (69.2–74.4) Ref  
1 indicator 15.8 (14.0–17.5) 1.62 (1.35–1.93) <.001 63.3 (61.0–65.6) 0.89 (0.85–0.93) <.001 69.8 (67.5–72.1) 0.97 (0.93–1.02) .202
2 indicators 21.7 (19.8–23.7) 2.23 (1.86–2.67) <.001 58.9 (56.5–61.2) 0.83 (0.79–0.87) <.001 67.4 (64.6–70.1) 0.94 (0.89–0.99) .028
3 indicators 28.5 (25.9–31.0) 2.92 (2.50–3.41) <.001 56.8 (54.2–59.4) 0.80 (0.76–0.84) <.001 63.1 (60.3–65.9) 0.88 (0.84–0.92) <.001
≥4 indicators 39.0 (37.2–40.8) 4.00 (3.37–4.74) <.001 49.4 (47.5–51.4) 0.69 (0.66–0.73) <.001 55.1 (53.0–57.2) 0.77 (0.73–0.81) <.001
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There are several limitations to this work. First, the SDOH 
and care outcomes were assessed cross-sectionally among a 
different sample of participants each year rather than longitu-
dinally among the same participants over time. Second, the re-
sponse rate among participants was suboptimal. However, the 
effect of nonresponse bias is mitigated by the complex survey 
design and poststratification weighting. Third, patient charac-
teristics and SDOH measures were based on self-report and 
may be subject to misclassification, although we do not suspect 
any measurement error to be differential with respect to HIV 
care outcomes. Finally, the OSHI is derived from items from the 
core MMP interview questions, which may not effectively con-
sider other risk factors associated with social inequities. Future 
iterations of OSHI could include facilitating factors and resil-
ience measures that could potentially offset the impact of social 
and economic disadvantage on health [28].
Clinical and Public Health Implications
We demonstrated the utility of the OSHI, a simple index using 
10 easily assessed items representing the 5 key domains of 
SDOH [12]. The strength of the associations between our com-
posite SDOH measure and HIV care continuum outcomes indi-
cates that the OSHI may be a useful tool for clinical assessment, 
planning and resource allocation, policy-making, and research 
and evaluation.
Our findings provide further evidence that the social and ec-
onomic needs of PWH will affect care outcomes and reiterate 
the need to collect and consider data related to SDOH as part of 
comprehensive HIV care [8, 29]. HIV case managers frequently 
use acuity scales to assess the nonclinical needs of PWH, and 
based on this assessment, provide referrals to relevant services 
to support HIV clinical care [18]. However, even the most ef-
ficient of scales can be time-intensive. In addition, depending 
on the location of care or clinic resources, medical case man-
agement may not be part of all clinical encounters with PWH, 
including among newly diagnosed individuals. The OSHI, 
therefore, represents an opportunity for providers to conduct 
a brief assessment of SDOH that can inform appropriate active 
referrals to services and facilitate warm hand-offs to case man-
agers, social workers, or community health workers. Similar 
SDOH assessment tools have been implemented in pediatric 
practices. Patients and families screened with evidence-based 
SDOH assessment tools and referred to services are more likely 
to be engaged with community resources on follow-up com-
pared with those who are not [30, 31].
In practice, the 10-item OSHI may be operationalized 
and implemented through a face-to-face assessment, a self-
completed questionnaire, or through an electronic system to 
collect patient-reported outcomes. Similar to assessment with a 
case management acuity scale, patients with a high OSHI could 
be prioritized for additional support services, referrals, and/or 
more frequent follow-up. Moreover, the brevity of the OSHI 
could make regular re-assessment of SDOH and routine clinical 
outcomes over time more feasible and may more quickly iden-
tify patients for whom support should be escalated or can be 
de-escalated. We also found that, with respect to durable viral 
suppression, an 8-item score performs similarly to our original 
10-item score.
Important priorities for future evaluation include assessing 
how the OSHI predicts HIV care outcomes longitudinally and 
comparing the predictive power of the OSHI to the in-depth 
acuity scales that many Ryan White programs currently use. 
Further work is also required to evaluate the reliability and va-
lidity of the OSHI in other samples of PWH. Finally, the OSHI 
could be useful in future research studies at the individual and 
population levels, providing a composite measure of SDOH. In 
studies of small samples, such a composite measure can be used 
in statistical models without losing power.
Fewer than 70% of PWH in the United States have achieved 
durable viral suppression [4, 5]. As we pursue HIV elimina-
tion efforts at local, state, and national levels, we must focus 
on increasing viral suppression rates among those clients who 
have not equally benefitted from clinical advances in HIV care 
and prevention [32]. Indeed, removing barriers to HIV care 
and treatment may have the largest impact on HIV elimina-
tion efforts [33]. The integration of the OSHI into local, state, 
and federal HIV surveillance systems, like MMP, may provide 
a more robust, intersectional assessment of disparities in viral 
suppression. The identification of economic and social disad-
vantage at the population level can then be used to advocate 
for policy changes at the local, state, and federal levels. For 
example, the most common OSHI measure reported among 
US PWH was poverty. Thus, policies related to microfinance, 
a higher minimum wage, basic universal income, and other 
programs to lift people out of poverty may result in improved 
health outcomes [34].
In conclusion, data from a large surveillance study of US 
PWH provide empirical evidence that access to SDOH matters 
for the health of PWH and that cumulative exposure to social 
and economic disadvantage significantly impacts key care out-
comes. The OSHI, a brief, easily constructed tool, has the po-
tential to improve outcomes among PWH through the efficient 
assessment of SDOH in clinical, public health, and research 
contexts.
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